Success Stories: EB-1A Approved for Translational Research and Molecular Pathology Researcher Advancing Cancer Biomarkers and microRNA-Guided Therapies following RFE
Client’s Testimonial:
“Thank you so much to all the attorneys and back-end team who helped me at various levels of filing and got it done positively in a short span of time as well.”
On August 14th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Researcher in the field of Translational Research (Approval Notice).
General Field: Translational Research
Position at the Time of Case Filing: Researcher
Country of Read more [...]